BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20227011)

  • 1. Renal pelvic urothelial carcinoma with divergent morphology.
    Xiao GQ; Unger PD
    Ann Diagn Pathol; 2010 Apr; 14(2):74-80. PubMed ID: 20227011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting.
    Gupta R; Paner GP; Amin MB
    Adv Anat Pathol; 2008 May; 15(3):127-39. PubMed ID: 18434765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial carcinoma of the upper urinary tract: comparison between the WHO/ISUP 1998 consensus classification and WHO 1999 classification system.
    Holmäng S; Johansson SL
    Urology; 2005 Aug; 66(2):274-8. PubMed ID: 16098355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology and staging of urothelial tumors of the kidney and ureter.
    Melamed MR; Reuter VE
    Urol Clin North Am; 1993 May; 20(2):333-47. PubMed ID: 8388136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry.
    Lopez-Beltran A; Requena MJ; Alvarez-Kindelan J; Quintero A; Blanca A; Montironi R
    J Clin Pathol; 2007 Mar; 60(3):332-5. PubMed ID: 16882698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary carcinoma of the renal pelvis and ureter. Evaluation of clinical and pathologic features.
    Strobel SL; Jasper WS; Gogate SA; Sharma HM
    Arch Pathol Lab Med; 1984 Sep; 108(9):697-700. PubMed ID: 6547821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
    Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.
    Perez-Montiel D; Wakely PE; Hes O; Michal M; Suster S
    Mod Pathol; 2006 Apr; 19(4):494-503. PubMed ID: 16474378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome.
    Holmäng S; Lele SM; Johansson SL
    J Urol; 2007 Jul; 178(1):51-6. PubMed ID: 17574059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoid-cell variant of urothelial carcinoma: a clinicopathologic and immunohistochemical study of five cases.
    Leroy X; Gonzalez S; Zini L; Aubert S
    Am J Surg Pathol; 2007 May; 31(5):770-3. PubMed ID: 17460462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas.
    Goto K; Konomoto T; Hayashi K; Kinukawa N; Naito S; Kumazawa J; Tsuneyoshi M
    Mod Pathol; 1997 May; 10(5):428-37. PubMed ID: 9160306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
    Goel MC; Mahendra V; Roberts JG
    J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nested variant of urothelial carcinoma of the renal pelvis.
    Lau SK
    Pathol Res Pract; 2009; 205(7):508-12. PubMed ID: 19171439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000.
    David KA; Mallin K; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
    Cancer; 2009 Apr; 115(7):1435-47. PubMed ID: 19215030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
    BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proposal for a novel staging system in renal pelvicaliceal urothelial carcinomas.
    Cho KS; Cho DS; Choi YD; Hong SJ; Kim SJ; Cho NH
    Hum Pathol; 2007 Nov; 38(11):1639-48. PubMed ID: 17651786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival.
    Park J; Ha SH; Min GE; Song C; Hong B; Hong JH; Kim CS; Ahn H
    J Urol; 2009 Sep; 182(3):894-9. PubMed ID: 19616243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.